• Cyclooxygenase: Cells can use prostaglandin-endoperoxide synthase 1 (i.e. cyclooxygenenase-1 or COX-1) and prostaglandin-endoperoxide synthase 2 (COX-2) to metabolize arachidonic acid primarily to prostaglandins but also to small amounts of 11(R)-HETE and a racemic mixture of 15-HETEs composed of ~22% 15(R)-HETE and ~78% 15(S)-HETE. (wikipedia.org)
  • Both of these metabolites, depending on the cell type which forms them, can be further metabolized to 15-oxo-eicosatetraenoic acid (15-oxo-ETE), 5(S),15(S)-dihydroxy-eicosatetraenoic acid (5(S),15(S)-diHETE), 5-oxo-15(S)-hydroxyeicosatetraenoic acid (5-oxo-15(S)-HETE), a subset of specialized pro-resolving mediators viz. (wikipedia.org)
  • Although less is known about an additional receptor, cysLT2, emerging evidence indicates that it likely also contributes to cysLT actions promoting inflammation, vascular permeability, and perhaps fibrosis. (springer.com)
  • Here we evaluated the efficacy of montelukast, a cysteinyl leukotriene receptor antagonist widely used to treat asthma in children, to ameliorate peripheral and central inflammation, and subsequent grey matter neuropathology and behaviour deficits in a mouse model of EoP. (biomedcentral.com)
  • Henderson WR Jr The role of leukotrienes in inflammation. (jamanetwork.com)
  • Volovitz BOsur SLBernstein JMOgra PL Leukotriene C4 release in upper respiratory mucosa during natural exposure to ragweed in ragweed-sensitive children. (jamanetwork.com)
  • Cysteinyl (cys) LTs C 4 , D 4 , and E 4 are long known to contribute to airway contractile responses via ligation of the cysLT1 receptor, and cysLT1 antagonists are beneficial in some patients with asthma. (springer.com)
  • Bisgaard HOlsson PBende M Effect of leukotriene D4 on nasal mucosal blood flow, nasal airway resistance and nasal secretions in humans. (jamanetwork.com)
  • Human cells release arachidonic acid (i.e. 5Z,8Z,11Z,14Z-eicosatetraenoic acid) from its storage site in phospholipids by reactions that involve phospholipase C and/or lipase enzymes. (wikipedia.org)
  • Peptide leukotriene release after antigen challenge in patients sensitive to ragweed. (jamanetwork.com)
  • Their unique chemical structures, receptors, and bioactions are being elucidated. (frontiersin.org)
  • Lipoxins, resolvins, protectins, and maresins are SPM derived from polyunsaturated fatty acids that limit excessive leukocyte infiltration and pro-inflammatory signals, stimulate innate microbial killing, and enhance resolution. (frontiersin.org)
  • Specifically, a 12.5-mg/kg dose of 1-NN to O 3 -tolerant rats produced significantly higher levels of cysteinyl-leukotrienes in bronchiolar lavage fluid even when compared to a 50-mg/kg dose of 1-NN in rats exposed to filtered air. (nih.gov)
  • To review the role of cysteinyl leukotrienes (cysLTs) in allergic rhinitis and the scientific rationale for therapy with leukotriene receptor antagonists (LTRAs). (nih.gov)
  • However this enzyme has a preference for metabolizing linoleic acid rather than arachidonic acid. (wikipedia.org)
  • It therefore forms linoleic acid metabolites (e.g. 13-hydoxyperoxy/hydroxy-octadecadienoic and 9-hydroperoxy/hydroxyl-octadecadienoic acids) in greater amounts than 15(S)-HpETE and 15(S)-HETE. (wikipedia.org)
  • Using a metabolomic approach, we investigated inflammatory responses in arachidonic and linoleic acid biochemical cascades (35 metabolites) and the expression of 19 cytokines/chemokines at three time points (2, 6, and 24 hr) following exposure to 1-NN with and without prior long-term O 3 exposure. (nih.gov)
  • Both of these metabolites, depending on the cell type which forms them, can be further metabolized to 15-oxo-eicosatetraenoic acid (15-oxo-ETE), 5(S),15(S)-dihydroxy-eicosatetraenoic acid (5(S),15(S)-diHETE), 5-oxo-15(S)-hydroxyeicosatetraenoic acid (5-oxo-15(S)-HETE), a subset of specialized pro-resolving mediators viz. (wikipedia.org)
  • Human cells release arachidonic acid (i.e. 5Z,8Z,11Z,14Z-eicosatetraenoic acid) from its storage site in phospholipids by reactions that involve phospholipase C and/or lipase enzymes. (wikipedia.org)
  • In addition, O 3 exposure activates epithelial cells and inflammatory cells to release cytokines, chemokines, and arachidonic acid. (nih.gov)
  • These lipid mediators act locally and systemically by interacting with receptors, particularly the cysLT1 receptor, on target cells. (nih.gov)